First, many studies have shown that polymorphisms in genes such as PNPLA3, HSD17B13, TM6SF2, MBOAT7, and GCKR might play the important roles in the occurrence and development of NAFLD and CKD [17]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.